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VITILIGO *
AARON B. LERNER, M.D., Ph.D.
Physicians frequently ask two questions about
problems in pigmentation: Why do patients with
Addison's disease develop hyperpigmentation,
and what is the mechanism of depigmentation
in vitiligo? These questions touch on problems
which are not only basic to an understanding
of the metabolism of the pigment forming cell
but also are of practical importance to the
afflicted patients. The first question was answered
when it was shown that the hyperpigmentation
of Addison's disease results primarily from in-
creased output of the melanocyte stimulating
hormone (MSH) by the pituitary gland (1).
After MSH was found to be an important physi-
ologic darkening agent, it was used to assay for a
potent lightening agent, which may be the factor
responsible for vitiligo. In this paper it will be
shown that vitiligo probably results from in-
creased output at the peripheral nerve endings of
a substance that lightens melanocytes.
This study of vitiligo was approached from
three directions: statistical, clinical and meta-
bolic. As will be shown in the statistical data,
vitiligo is a common disease. From the more than
600 letters received from patients with vitiligo,
it is clear that this is a skin disease which does not
interfere with the normal life expectancy but
which may disrupt the whole pattern of a life.
Take one example:
"Dear Doctor:
I have a certain pigmentation known as vitiligo
skin discolor. In the summer it is at its worst
because of the sun. My hands are completely
white and parts of my face and feet and elbows
and neck. I have lost so much in life because of
this discoloration. I don't have any money and
right now I don't have a job. Because every sum-
mer it seems to get much worse, I am really dis-
figured. I would do anything if my skin would
clear up. I have so many unfavorable remarks.
And people who notice say, 'What's wrong with
you? It isn't catching is it?' I have had to fight
since I was small. And today I try to hide myself
in shame..
* From the Section of Dermatology, Depart-
ment of Medicine, Yale University School of Medi-
cine, New Haven, Connecticut.
Some of the experiments reported here were
carried out by the author at the University of
Oregon Medical School with the technical assist-
ance of John R. Peterson.
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When one appreciates the concern felt by the
white vitiligo patient, it is easy to understand
the distress experienced by members of darker
races in whom the pigmentary defect is more
obvious. Small wonder then that when Prime
Minister Nehru spoke before a group of drug
manufacturers some years ago he expressed hope
that advances would be forthcoming to help
patients with the three most important diseases
in India: tuberculosis, leprosy and vitiligo.
STATISTICAL STIJDv
A questionnaire was sent to 250 people with
vitiligo, 128 of whom answered. An additional
72 questionnaires were completed on patients
with vitiligo examined by the author. The 200
questionnaires were tabulated for analysis. The
results are shown in Table I. A synopsis of these
data is given in Table II in which only approxi-
mate values for each entry have been used in
order to provide a simple reference to statistics
on vitiligo. Most of the points raised in the ques-
tionnaire will be discussed individually.
Race was designated white in 188 answers and
non-white in 12.
There were 135 females and 65 males.
The data were first divided into two major
groups depending on whether the questionnaires
had been answered by mail or filled out by the
author after personal interviews. These two groups
were subdivided into two more according to the
sex of the patient. The data from the resulting
four groups were compared. Because no signifi-
cant differences were found, the questionnaires
were regarded subsequently as a single unit.
Sex: Although 135 of the questionnaires were
answered by females and 65 by males, it is not
known whether the incidence of vitiligo differs
in the two sexes. Females are assumed to be
more interested in treatment of a disfiguring
process than males. It is possible that vitiligo
occurs with equal frequency in men and women
(2).
Race: The people in this study were primarily
white. Only 12 of the 200 questionnaires came
from non-white persons, including Negroes,
Orientals, and Indians. There is no reason to
expect that race alone could make for differences
in pathogenesis of vitiligo. However, as will be
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VITILTGO QUESTIONNAIRE
Name________ Age Race___Address
Name of your present doctor —
Your age when you first developed vitiligo Marital status__________________
Part of the body involved first
Does your father have vitiligoL_
Does your mother have vitiligo?
Do your brothers have vitiligo? -___________________
Do your sisters have vitiligo?_____ —______
Do your cousins, aunts, uncles or relatives have vitiligo?_
Do you think your vitiligo is associated with (or caused by) any particular event such as emo-
tional npset, accident, sunburn, etc.?_
Before you developed vitiligo, did you tan or burn when you went out in the sun?____________
What factors make your vitiligo spread
Did pregnancy affect your vitiligo?__
What illnesses besides vitiligo do you have at the present timey
Have any of the areas of vitiligo ever gotten their color baek?
Do you have any other contribution of facts or ideas that might help us in the scientific study
of vitiligo? (Answer on back of page)
PLEA5E RETURN IN TilE 5ELF-AUDEE55ED ENVELOPE
shown later, the darker the skin the greater may
be the susceptibility to vitiligo. Consequently,
vitiligo may be more prevalent in the dark
skinned races.
Age of onset of vitiligo: Vitiligo usually begins
in the younger age groups. Approximately 50
per cent of the patients first noted some form of
the disease before the age of twenty (Table I).
The onset of vitiligo was observed in an infant
eight months old and in an adult of over seventy
years.
Initial involvement: Most persons answering
this question indicated that only one part of the
body was affected first; less than 25 per cent
noted primary involvement of multiple sites.
Excluding the latter, vitiligo was detected first
on the hands, arms, neck, or face. It could be
argued that these areas are most open to inspec-
tion and that perhaps depigmentation begins
with equal frequency on all parts of the body.
However, most people with vitiligo have well
pigmented skin so that depigmentation readily
becomes apparent. Furthermore, these same sites
are the ones most commonly involved in vitiligo
of several years' duration. Depigmentation tends
to develop in skin exposed to sunlight or in warm
regions of the body.
Relatives with vitiligo: Seventy-six out of 198
persons, or 38 per cent, had blood relatives with
vitiligo. Thirty-six had one relative, 23 had two,
13 had three, and three patients had four or
more relatives with vitiligo. In four instances
questionnaires were obtained on two members
of the same family.
Thirty-eight per cent is probably a minimum
figure for the relative frequency of vitiligo in
patients who have other family members with
vitiligo. Many subjects had little contact with
their relatives. In addition, vitiligo may not
develop in some members of the family until
later in life.
Analysis of the individual questionnaires sup-
ports the view that vitiligo is often inherited,
probably as a dominant trait, with modifying
factors influencing an otherwise expected 50 per
cent affected in each generation. In one family,
four members had vitiligo—only those with
brown eyes. At least in this case there may be a
TABLE I
Data on Vitiligo Obtained from Two Hundred
Questionnaires
Num- Per
ber Cent
Age of Onset in Years
0—19
20—39
40—59
60—up
Total
Initial Involvement
Hands
Arms
Neck
Face
Legs
Back
Groin and/or genitals
Axilla
Chest
Abdomen
Head
Multiple sites
Total
Exposed areas
Unexposed areas
Both
Total
Individuals with Relatives having
Vitiligo
Relatives with vitiligo
No relatives with vitiligo
Total
Onset of Vitiligo Associated with
Some Event
Emotional upset
Nervousness
Illness
Accident
Operation
Sunburn
Pregnancy
Delivery
None
Total
Emotional upset or nervousness...
Accident, operation, illness, sun-
burn
None
Total
VITILIGO 287
TABLE I—(Continued)
Num- Per
ber Cent
93
83
19
4
199
56
22
22
18
12
6
6
5
3
3
1
44
198
155
27
16
198
76
122
198
54
7
17
11
6
21
3
5
55
179
61
63
55
179
47
42
10
2
101
28
11
11
9
6
3
3
3
2
2
1
22
101
78
14
8
100
38
62
100
30
4
10
6
3
12
2
3
31
101
34
35
31
100
Reaction to Sunlight Prior to Onset
of Vitiligo
Tan 137 89
Burn 17 11
Total 154 100
Factors Causing Spread of Vitiligo
1)on't know 110 61
Not spreading 7 4
Sunburn 27 15
Nervousness 19 11
Pregnancy 3 2
Delivery 4 2
Trauma 9 5
Surgery 1 1
Total 180 101
Effect of Pregnancy on Vitiligo
No effect 38 61
Increased with delivery 19 31
Increased during pregnancy 4 7
Decreased during pregnancy 2 3
Females ever pregnant while
having vitiligo 62 102
Illnesses Other than Vitiligo
None 105 5S
Possible psychosomatic disorders
and nervousness 57 31
Possible hyperthyroidism 5 3
Possible hypothyroidism 1 1
Arthritis 12 7
Diabetes 2 1
Total 182 101
Repigmentation
Entire Group of Patients:
Some repigmentation 87 44
No repigmentation 110 56
Total 197 100
Patients with Vitiligo of at Least
Two Years' Duration:
Some repigmentation 87 49
No repigmentation 92 51
Total 179 100
Incidence of Vitiligo
Nevada, Missouri—15 people with vi-
tiligo out of 8,000: 0.19%
Pendleton, Oregon—2O people with vi-
tiligo out of 14,000: 0.14%
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Incidence of vitiligo in the general
population
Age of onset:
Before 20 years
21—40 years
After 40 years
Onset of vitiligo associated with some
event
Onset of vitiligo associated with emo-
tional trauma or nervousness
Part of body involved first:
Exposed areas
Unexposed areas
Reaction to sunlight prior to onset of
vitiligo:
Tan
Burn
Some degree of repigmentation
Individuals having relatives with vi-
tiligo
Factors causing spread of vitiligo:
Don't know
Sunburn
Nervousness
Concurrent illness:
None
Nervousness or psychosomatic dis-
order
Effect of pregnancy on vitiligo:
No effect
Increased with delivery
linkage of genes for vitiligo and brown eyes.
These findings are not in accord with the view
that vitiligo is seldom inherited (3—5).
Association of onset of vitiligo with other events:
Before this study some workers, including the
author, had the clinical impression that vitiligo
often followed a severe stress reaction, usually
emotional in character, such as a marital quarrel,
death of a loved one, tension at work or a frighten-
ing accident. It is difficult to prove a causal con-
nection between stress reactions and the develop-
ment of vitiligo. People have a tendency to date
illnesses by traumatic events. However, so many
vitiligo patients relate vivid accounts which have
a basic similarity that it seems possible that a
severe stress reaction might precipitate vitiligo
in the predisposed person.
Thirty per cent of the people reached in the
survey claimed that an emotional upset pIe-
ceded the vitiligo. Another 39 per cent attributed
the disease to nervousness, accidents, illnesses,
Per cent
operations or parturition. Thus 69 per cent of the
persons studied associated the onset of vitiligo
1 with a stress reaction, and 31 per cent did not.
Reaction to sunlight: Most patients with vitiligo
50 had good capacity for pigmentation before de-
45 veloping vitiligo. After the occurrence of depig-
5 mentation, they continue to pigment easily in
the non-vitiliginous areas. This is evident from
70 the finding that 89 per cent of the respondents
considered themselves good suntanners, while
only 11 per cent burned easily. Two patients
80 claimed they burned on exposure to sunlight
20 prior to onset of vitiligo but tanned readily in
the non-vitiliginous areas after development of
the disease. Many answers to the question on
90 suntanning were ambiguous and had to be dis-
10 carded, so that only 154 questionnaires with clear-
50 cut answers were studied on this question.
Factors causing spread of vititigo: The depig-
mentation tends to progress with increasing dura-
tion of the disease. Most of the patients did not
know what caused extension of the process. A
15 few said that it was no longer spreading. An
attempt was made to distinguisk between actual
50 new formation of vitiligo and an apparent in-
crease due to contrast between tanned and depig-
35 mented areas following exposure to sunlight.
Fifteen per cent of the patients considered sun-
60 burn responsible for the spread of vitiligo. Nerv-
30
ousness was thought important by 11 per cent.
Other factors mentioned were physical trauma,
surgery, pregnancy, and delivery.
Effect of pregnancy on vitiligo: Sixty-two
women became pregnant some time during the
course of their vitiligo. Most observed no change
during or immediately following pregnancy, but
extension of the vitiligo immediately after de-
livery was noted by 31 per cent. An increase in
vitiligo during pregnancy was claimed by seven
per cent and a decrease by three per cent. In one
woman vitiligo decreased during pregnancy but
increased following delivery.
Illnesses other than vitiligo: Slightly over half
the patients denied other illnesses. This low in-
cidence may be spurious because, as found during
personal interviews, much questioning was re-
quired to draw out a history of diabetes, tuber-
culosis, arthritis, etc.
A disease with possible psychosomatic asso-
TABLE II
Summary of Vitiligo Statistics
CLINICAL FORMS OF VITILIGO
VITILIGO COMPLETE VITILIGO
SEGMENTAL VITILIGO PERIHALO NEVI
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Site of
Trauma
Remaining
Patch
GRAY HAIR
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ciation, or nervousness, was claimed by 31 per
cent. The former group included eczema, urti-
earia, alopeeia areata, migraine headache,
gastritis, peptic ulcer, etc. Five out of 183 pa-
tients mentioned hyperthyroidism. Of these, one
had a carcinoma of the thyroid gland. Two pa-
tients said that they had a low basal metabolic
rate and hypothyroidism. One of the latter
claimed to have had hyperthyroidism previously
which was followed by hypothyroidism, without
benefit of surgical or roentgenologie treatment.
The association of hyperthyroidism with vitiligo
will be discussed later.
Another impression, supported by a statistical
study (6), is that vitiligo frequently occurs in
patients with pernicious anemia. None of the
200 vitiligo patients reached in this study had
pernicious anemia. One questionnaire obtained
after completion of the study was from a patient
with pernicious anemia and vitiligo. Subse-
quently, the author examined four patients with
vitiligo and pernicious anemia.
Re pigmentation: Repigmentation, even though
slight, occurred at some time in 44 per cent of the
entire group. When only patients having vitiligo
for two or more years were considered, 49 per
cent were found to have experienced some degree
of repigmentation.
Incidence of vitiligo: Reports vary widely on
the incidence of vitiligo in the population at
large. In Switzerland, Robert (2) found that 0.39
per cent of patients in one dermatology clinic had
vitiligo. He reviewed the literature and stated
that similar studies in Leningrad showed 0.14
per cent affected, in London 0.42 per cent, and in
Japan 1.64 per cent. It has been remarked, but
without evidence, that the incidence of vitiligo
in India is about three per cent.
In order to get an approximate idea of the in-
cidence of vitiligo in this country, two persons
who live in small communities in different parts
of the United States were asked to find out how
many of their fellow citizens had vitiligo. One,
the mother of a child with vitiligo, observed 15
people with vitiligo in Nevada, Missouri—a
community of 8,000. Another, a patient with
vitiligo, observed 20 people with the same dis-
order in Pendleton, Oregon—a community of
14,000. In Nevada, Missouri the incidence was
0.19 per cent; and in Pendleton, Oregon it was
0.14 per cent. These figures are undoubtedly
very low because depigmentation even of the
exposed areas may not be conspicuous. Dr. L. E.
Gaul, in examining high school students in
Indiana, found eight eases of vitiligo in 250
males, an incidence of 3.2 per cent. It is probably
safe to assume that the incidence of vitiligo iu
this country is at least one per cent.
TERMINOLOGY AND CLAsSIFICATION
The word vitiligo is of Latin derivation and
means, literally, skin eruption. According to
present-day usage, vitiligo refers to idiopathic
depigmentation which begins after birth and is
usually progressive.
Leukodema is a more general term which in-
cludes the hypopigmentation of vitiligo, albinism,
burns or trauma, leprosy, syphilis, and pinta.
Clinically, vitiligo may assume various forms;
hence it is convenient to divide the disease ac-
cording to type as shown on the accompanying
chart and in Figures 1—4.
Suggested Terminulogy
Vitiligo: Commonest form
of vitiligo with depigmen-
tation of hands, face, axil-
las, etc., part of which
may be segmental in dis-
tribution.
Complete vitiligo: ordinary
vitiligo frequently ex-
tends so that most of the
body is involved. A few
pigmented spots may re-
main.
Segmental vitiligo: depig-
mentation segmental cor-
responding to nerve dis-
tribution, but some areas
within segment may he
spared.
Perihalo nevus: Depigmen-
tation surrounding a pig-
mented nevus. Later the
nevus itself may become
depigmented.
Fin. 2. Generalized vitiligo. Typical sites: a. Face, neck, umbilicus, hands, geni-
tals, legs, feet. b. Hands, back, thighs, feet. c. Face, axilla, hands. d. Face, neck.
Types of Vitiligo
Other Terms
Generalized vitiligo
Vitiligo vulgaris
Total vitiligo
Universal vitiligo
Localized vitiligo
Partial vitiligo
Focal vitiligo
Leukoderma acqul-
situm centrifu-
gum
Suttons disease
Figure 2a Figure 2b
Figure 2c Figure 2d
I
&
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FJG. 4. a. Segmental vitiligo. b. Segmental vitiligo. e. Segmental vitilige. d. Gen-
eralized vitilign with segmental distribution nn abdomen.
Figure 3a
Figure 3b
Tigure 3c
Figure 3d
FJG. 4. a. Segmental vitiligo. b. Segmental vitiligo. e. Segmental vitilige. d. Gen-
eralized vitilign with segmental distribution nn abdomen.
Figure Ia Figure lb
Figure Ic Fzgure Id
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The cause of the depigmentation may be the same
in all eases. The simple term, vitiligo, indicates
the commonest form. Alternative choices for the
same condition have been generalized vitiligo and
vitiligo vulgaris. After the disease has been pres-
ent a while, depigmentation usually is found on
the exposed areas and body folds, about external
orifices, and at sites of trauma. Other types of
vitiligo, for example, segmental depigmentation
and perihalo nevus, also may be present.
Complete vitiligo, also known as universal or
total vitiligo, represents an extension of the
process so that most of the body is depigmented.
In the majority of cases to which this term would
be applicable, a few pigmented spots remain.
Segmental vitiligo, in which depigmentation
occurs in the segment of distribution of one or
more nerves, also has been called localized,
partial, or focal vitiligo. The entire skin area
supplied by the nerve need not be involved, and
lesions characteristic of other types of vitiligo may
occur elsewhere on the body.
Perihalo nevus has been known as leukoderma
acquisitum centrifugum or Sutton's disease. The
lesion, a central nevus surrounded by a circle of
depigmentation, occurs frequently in patients
with vitiligo as well as in persons with normal
skin.
CLINICAL DESCRIPTION
The following clinical description of vitiligo is
based on direct observation and data obtained
from questionnaires of about 300 patients with
vitiligo.
The disease may begin at any age, but its on-
set is most common in young adults. Usually the
first lesions occur as depigmented spots on ex-
posed areas, such as the dorsal surfaces of the
hands, and the face and neck. However, the
body folds—axilla and groin—also may be the
initial sites. Location, size, and shape of individ-
ual lesions vary considerably. Yet the over-all
picture is characteristic.
Perhaps the most striking feature of vitiligo
is that in general the areas of depigmentation are
the same as those of hyperpigmentation found in
Addison's disease. In the latter condition hyper-
pigmentation may be pronounced in the exposed
areas, body folds, periumbilieal region, mucous
membranes, external orifices, sites of recent
trauma or pressure, and nevi. Vitiligo shows a
predilection for the identical areas (Fig. 5).
Usually depigmentation occurs first on the
backs of the hands and fingers. The flexor aspects
of the arms tend to be more involved than the
extensor. Facial lesions are common, especially
around the eyes and mouth. The eyelids are
affected similarly. Typical sites of depigmentation
include the neck, both anteriorly and posteriorly,
axillas, genitals, periumbilical and perianal re-
gions. Frequently the inner aspects of the thighs,
the knees, and the anterior aspects of the legs
and dorsal surfaces of the feet are involved. At
times the vitiliginous areas follow the path of a
nerve (Fig. 4). A few patients have only one area
of depigmentation, and that may be limited to
the distribution of some nerve. But in the usual
case there are multiple areas of involvement with
at most one or two patches corresponding to
nerve distribution. Sites of recent trauma often
are affected (Figs. 6 and 7). A perihalo nevus is
formed when depigmentation occurs about a
pigmented nevus. The nevus itself may lose its
color. The hair in patches of vitiligo may be pig-
mented or gray.
There may be varying degrees of pigmentation
in vitiligo with several shades of color occurring
in the same patient. Usually the normal appear-
ing skin is separated from the vitiliginous region
by a border which is hyperpigmented and at
times even inflammatory. The main portion of a
vitiliginous patch may be completely depig-
mented or merely lighter in color than the normal
skin. Sometimes an area of complete depigmenta-
tion is surrounded by a lightly colored broad
band, one to three cm. in width, which in turn is
separated from the normal appearing skin by a
hyperpigmented border.
Depigmentation may extend to involve the
entire body so that the patient has complete
vitiligo. Such a patient would rather be com-
pletely depigmented and have a uniform ap-
pearance than be a mottled spectacle.
Graying of hair is unpredictable. Some patients
whose vitiligo is limited in extent may have a lot
of gray scalp hair. Yet many patients with com-
plete vitiligo have little gray hair.
Although it would be a difficult point to prove
experimentally, it is possible that there is in-
creased pigmentation of the so-called normal
skin in vitiligo. Most of these patients tan readily
in the areas which are not depigmented. Ex-
posure to sunlight produces both repigmentation
and further depigmentation in the same patient.
Perifollieular repigmentation, ranging from a frae-
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FIG. 5
tion of a millimeter to a centimeter in diameter,
frequently occurs in vitiliginous patches following
exposure to sunlight. On the other hand, if the
nonvitiliginous areas become sunburned, depig-
mentation may develop as after any other type
of trauma to the skin. Vitiligo is more conspicuous
in the summer than winter because exposure to
sunlight tans the non-vitiliginous skin, thus
accentuating the contrast with the depigmented
area.
The onset of vitiligo frequently is associated
with severe physical or emotional trauma. One
patient observed depigmentation a few weeks
after being frightened while riding a run-away
horse. Another noted the lesions after being
wounded in World War I. A tlurd associated the
onset with the death of a close relative. In some
eases the lesions first developed in the wake of
a severe sunburn. Although the emotional status
of patients with vitiligo has not been studied
adequately, the impression is gained from seeing
many patients that vitiligo occurs in tense,
emotionally labile persons. Many of them state
that their friends consider them calm but that
inwardly they feel anxious and nervous. Some
patients show outward signs of anxiety. A parent
may claim that the vitiliginous child is not only
more nervous than his siblings but was so even be-
fore the onset of vitiligo.
It is difficult to know how much credence to
attribute to the impression that patients with
vitiligo are basically tense because physicians
USUAL VARIATIONS IN PIGMENTATION
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FIG. 6. Thorium-X-induced depigmentation in vitiligo. Note linear depigmentation of both hands
beginning on the medial aspects of the wrists and extending distally and laterally. This patient had
vitiligo involving the fingers and flexor aspects of the wrists. 8-methoxypsoralen in an alcoholic solution
of thorium-X was applied to the depigmented areas of the wrists in order to determine whether the alpha
radiations from thorium-X would substitute for ultraviolet light to effect repigmentation. During this
procedure the excess alcoholic solution ran down the dorsal surfaces of the hands. Depigmentation and
not hyperpigmentation followed the mild erythema reaction produced by irradiation. If the skin of a
normal individual, rather than one with vitiligo, had been tested, hyperpigmentation would have been
the result.
seeing large numbers of patients with other ill-
nesses—eczema, asthma, psoriasis, ete.—state
that their subjects also have high emotional
lability.
The course of vitiligo is variable, but complete
repigmentation seldom occurs spontaneously.
Usually there are periods of active spreading of
the disease as well as times when the process re-
mains stationary or even undergoes partial re-
gression. Extension of the disease often occurs
when the patient experiences great stress of
either an emotional or physical character.
Trauma to the skin frequently results in depig-
mentation. In time the vitiligo slowly extends or
reaches a state of quiescence.
The differential diagnosis of vitiligo may be
difficult. Ordinarily vitiligo can be determined
readily from the patient's history and appear-
ance. But abnormalities of pigmentation also
occur in other diseases.
All patients suspected of having vitiligo should
be examined under the Wood's light in order to
establish a marked contrast between the pig-
mented and hypopigmented skin. Depigmented
spots not visible by ordinary light can be de-
tected readily, and the expected sites of involve-
ment can be checked.
Hyperpigmentation of the face characteristic
of melasma may be confused with vitiligo if the
dark blotches are mistaken for normal skin color
U, ft
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Fin. 7. A skin biopsy from the abdomen of a Negro patient with vitiligo resulted in depigmentation
of the line of incision and suture marks. This trauma to the nonvitiliginous skin of a patient with vitiligo
produced depigmentation, whereas hyperpigmentation would have occurred in a normal person.
and the adjacent normal skin is considered
hypopigmented. However, examination of the
rest of the body reveals normal or hyperpig-
mented skin rather than vitiligo. Melasma or-
dinarily is associated with pregnancy, Addison's
disease, or a chronic illness. In these conditions
urine melanocyte stimulating hormone (MSH)
may be increased whereas it is usually normal in
vitiligo.
In partial albinism the depigmented lesions
which are present from birth enlarge only with
the growth of the person and are not bordered
by hyperpigmentation. New lesions do not ap-
pear as time goes by. A white forelock is often
present. Vitiligo, on the other hand, occurs after
birth. The lesions may grow rapidly and often
are surrounded by a hyperpigmented border. New
lesions continue to develop. There is seldom a
white forelock. Interestingly enough, both vitiligo
and partial albinism may be transmitted geneti-
cally as dominant traits, whereas complete albin-
ism is a recessive trait.
Patients with eczema and psoriasis who are
undergoing remission while exposed to sunlight
may not tan in the involved areas. After clearing
of the dermatitis, remaining hypopigmented
patches may simulate vitiligo.
The involved areas of tinea versicolor do not
tan in the summer and by contrast with the ad-
jacent dark skin may appear vitiliginous. How-
ever, the mycotic lesions predominate on the
trunk and upper extremities; and on close in-
spection scaling is seen.
Depigmentation occurs in other infections:
syphilis, pinta, and leprosy. It is a late and un-
common manifestation of syphilis. Whereas
hyperpigmentation occurs early in the course of
pinta, extensive depigmentation may develop
later. With early treatment repigmentation may
take place. In leprosy hypopigmented macules
occur, especially in the tuberculoid type in which
skin lesions are co-extensive with nerve involve-
ment.
METABOLIC STUDY
The following laboratory tests were carried
out on patients being treated for vitiligo: urine
noradrenaline, 17-ketosteroids, and melanocyte
stimulating hormone excretion, gastric analysis
before and after histamine, serum protein bound
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iodine, J131 uptake by the thyroid gland, basal
metabolic rate, serum copper, thymol turbidity,
cephalin cholesterol flocculation, skin tempera-
ture, and sweat measurements. As shown in
Table III, there were 5 males and 20 females
ranging in age from 12 to 61 years. Two of the
males were Negroes and the remaining 23 pa-
tients were white. Three of the patients had
segmental vitiligo confined to part of the face.
One patient had complete vitiligo. The remaining
21 patients had vitiligo of the usual sites. The
duration of the disease ranged from 1 to 38 years.
The degree of emotional tension was considered
severe in 17 patients, moderate in 5, and mild in
3. Two of the patients had hypertension, and 1
each had alopecia areata, neurodermatitis,
multiple allergies, and duodenal ulcer.
Efforts were made to carry out the laboratory
tests on all 25 patients, but this was not possible
for a variety of reasons. Sometimes the patient
could not supply a 24-hour urine specimen. On
other occasions a blood sample would be lost
when a tube broke in the centrifuge. Or a patient
was unable to keep his appointment. Neverthe-
less, the tests were done on most of the patients.
Noradrenaline: Since noradrenaline has a
marked lightening effect on frog skin (see Fig. 8)
and because it is released at some peripheral
nerve endings in human skin it was desirable to
determine this compound in the urine of patients
with vitiligo. The excretion of noradrenaline was
measured in five patients with actively pro-
gressive vitiligo. As shown in Table I'V the re-
suits were within normal limits.
Gastric analyses: In 1931 Francis reported that
four patients with vitiligo had no free hydro-
chloric acid in the gastric juice before or after a
test meal (7). Since then scattered reports have
appeared on the association of vitiligo with
achlorhydria or hypochlorhydria (8, 9).
In the present study gastric analyses performed
as described by Ham (10) showed achiorhydria
in 1 out of 5 males and 2 out of 15 females. The
male without free hydrochloric acid was 61 years
Patient Sex Age
TABLE III
Clinical Data on Patients &udied
Type of vitiligo
Dura-
tion
(Years)
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
M
M
M
M
M
F
F
F
F
F
F
F
F
F
F
F
F
F
F
F
F
F
F
F
F
14
28
32
42
61
12
14
17
20
27
29
33
34
34
36
36
38
38
38
41
45
47
53
54
54
Segmental
Segmental
Generalized
Generalized
Generalized
Segmental
Generalized
Complete
Generalized
Generalized
Generalized
Generalized
Generalized
Generalized
Generalized
Generalized
Generalized
Generalized
Generalized
Generalized
Generalized
Generalized
Generalized
Generalized
Generalized
1
16
10
34
38
1
7
3
17
10
6
10
3
17
27
19
24
18
4
25
25
10
25
6
Location
Face
Face
Common sites
Common sites
Common sites
Face
Common sites
Most of body
Common sites
Common sites
Common sites
Common sites
Common sites
Common sites
Common sites
Common sites
Common sites
Common sites
Common sites
Common sites
Common sites
Common sites
Common sites
Common sites
Common sites
Emotional Tension
State
Severe
Severe
Severe
Severe
Mild
Severe
Severe
Severe
Mild
Moderate
Severe
Severe
Severe
Mild
Severe
Severe
Moderate
Moderate
Severe
Severe
Severe
Moderate
Severe
Severe
Moderate
Other Illnesses
None
Duodenal ulcer
None
None
Hypertension
None
None
Alopecia areata
None
None
None
Neurodermatjtjs
None
None
None
None
Hypertension
None
None
Allergies
None
Low BMR
None
None
None
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old. This finding was not unexpected because
anacidity occurs in one-third of the men in this
age group (11). Free hydrochloric acid was absent
in 13 per cent of the females, a value comparable
to the incidence of anacidity in normal subjects
(11). However, 3 of the 5 males and 12 out of 15
females showed less than 70 units of free hydro-
chloric acid after histamine. The lower limits of
normal for free hydrochloric acid after histamine
usually vary from 70 to 90 units depending on
the age and sex of the patient (10, 11). If these
limits are accepted, then the average female pa-
tient with vitiligo secretes less than the nor-
mal amount of free hydrochloric acid after his-
tamine.
Sweat measurements: In patients with vitiligo
equal quantities of sweat are formed in the viti-
liginous and pigmented areas when the sweat
glands are stimulated by heat or chemical means
(12). Thus the capacity of the sweat glands to
react is the same in both regions. But it was not
known whether the moisture content differed
when the patient with vitiligo was at rest. To
this end a neuro-dermometer was used to meas-
ure differences in the electrical resistance of viti-
liginous and pigmented skin. The greater the
galvanometer reading, the more moisture present
on the skin. Results of sweat studies on five
patients are shown in Table VI. In each ease
there was decreased resistance in the vitiliginous
area compared with the pigmented control sites.
Measurements were made of skin adjacent to
the area of vitiligo or of the eontralateral pig-
mented site if present. It was concluded that
vitiliginous skin is a better electrical conductor
than pigmented skin. In ease No. 16 a striking
diflerenee was detected between the depig-
mented area of a perihalo nevus, which gave a
reading of 100, and the surrounding pigmented
skin, with a reading of five. The increased con-
ductivity is most likely associated with the
moisture content of the skin, and under resting
conditions there may be greater activity of the
sweat glands in the areas of vitiligo than in non-
viliginous sites. Additional sweat measurements
were made later with the help of Dr. Robert
Crounse. These studies confirmed the above
findings.
Skin temperature: A thermocouple was used
to measure the temperature of the skin surface
in patients Nos. 5 and 16. Readings taken in
many of the areas of normal and vitiliginous skin
showed only random differences in temperature.
Thyroid function: On the basis of clinical ob-
servations, vitiligo has been reported to be fre-
quent in patients with early hyperthyroidism and
Graves disease, although in the latter hyper-
pigmentation is often the case (2). Robert (2)
observed elevated basal metabolic rates in ten
out of 20 patients with vitiligo. Because of these
reports it was decided to measure thyroid func-
tion by three methods. The serum protein bound
iodine (FBI) was determined in 24 of the 25 pa-
tients, the I's' uptake in 20 out of 25, and the
basal metabolic rate (BMR) in 18 out of 25
(Table VII). All the FBI tests were within normal
limits. A few values for I's' uptake were border-
line, being elevated in two patients and at the
lower limits of normal in one. Of the two patients
with increased I's' uptake, patient No. 17 had
hypertension; but patient No. 20 had no illness
other than vitiligo. Fatient No. 22, whose J131 up-
take was low, had had hyperthyroidism several
years previously while in high school, followed
by hypothyroidism with a basal metabolic rate
of —17 per cent. For the past several years she
had been taking 1.5 grains of thyroid extract
daily. The exogenous thyroxine could depress the
uptake of Jill and account for the low value given
in the table. The BMR of —17 was obtained four
weeks after the patient had discontinued thyroid
medication. Fatient No. 14 had been taking two
grains of thyroid daily for several months be-
cause her BMR was said to be —36 per cent.
After she discontinued thyroid medication for
four weeks, FBI, 1131 and BMR determinations
were done. All tests were normal. With four ex-
ceptions the basal metabolic rates were within
normal limits. The mild hypothyroidism of pa-
tient No. 22 had been preceded by hyperthy-
FIG. 8. Microscopic picture of two identical folds of frog skin. MSH or caffeine
causes dispersion of pigment granules and darkening of skin. Melatonin or nor-
adrenaline causes aggregation of granules and lightening of skin, a. Left, normal;
right, after melatonin or noradrenaline. Decrease in color of frog skin after addition
of melatonin or noradrenaline. b. MSH or caffeine. c. Melatonin or noradrenaline.
Figure 8a
Figure 8b
Figure 8c
SI
. 
A 
•
 
•
 
h 
305
TABLE IV
Urine Noradrenaline
Normal range: 14—41 micrograms per 24 hours.
TABLE V
Gastric Analysis
pH and free hydrochloric acid of gastric fluid
obtained from fasting patients before and thirty
minutes after subcutaneous injection of 0.5 mg.
of histamine.
Normal range:
Fasting: 0—30 units hydrochloric acid.
After histamine: 70—125 units hydrochloric acid.
.
a ten Urine NnradrenalineMirrngrams per 24 hnurs
1 —
2 —
3 25.7
4 33.6
5 —
6 —
7 —
8 —
9 .—
10 —
11 —
12 32.0
13 —
14 —
15 17.0
16 19.0
17 —
18 —
19 —
20 —
21 —
22 —
23 —
24 —
25 —
Average 25.5
Patient
1
2
3
4
5
6
7
8
9
13
ii
12
13
14
15
16
17
18
19
20
21
22
23
24
25
Sex
M
1W
M
1W
1W
F
F
F
F
F
F
F
F
F
F
F
F
F
F
F
F
F
F
F
F
Age(years)
14
28
32
42
61
12
14
17
20
27
29
33
34
34
36
36
38
38
38
41
45
47
53
54
54
pll
After
Fasting Hista-
mine
6.7 2.7
1.8 1.1
6.5 1.7
1.8 1.2
7.1 5.5
2.0 1.7
6.5 1.8
7.8 3.4
5.4 1.4
8.5 1.8
4.5 1.4
7.5 6.1
6.8 1.2
2.1 1.4
6.2 1.6
2.2 1.6
2.2 1.6
6.8 1.5
4.5 1.5
Hydrnrhlnrir
Arid Units
After
Fasting Hista-
mine
0 3
23 129
0 44
30 129
0 0
33 73
0 49
0 4
0 39
0 21
0 87
0 0
0 57
0 0
13 71
0 47
9 56
11 55
0 51
0 40
roidism many years ago. Of the three patients
with increased basal metabolic rates, it can be
seen from Table VIII that one was very appre-
hensive. This may account for the increased
rate. The other two had normal FBI levels and
Jt3s uptakes. It is likely that most patients with
vitiligo have normal thyroid function, contrary
to earlier reports in the literature. However, pa-
tients with hyperthyroidism probably have an
increased incidence of vitiligo. Since completion
of this study the author has observed ten patients
with hyperthyroidism and vitiligo.
1 7-ketosteroid excretion: These tests were done
to get an idea of adrenal cortical activity al-
though it is realized that the exact significance
of high or low excretion of 17-ketosteroids in the
urine is not known. It has been assumed that a
low value indicates hypofunction and a high value
hyperfunetion of the adrenal cortex. Four out of
five males and four out of 15 females had low 17-
kctosteroid excretion values (Table IX). In
one female these steroids were increased. It is
probably best not to speculate here on the mean-
ing of the low values.
Melanocyte stimulating hormone (MSH) excre-
tion: This hormone is produced by the pituitary
gland, and a measurement of its excretion in the
urine gives an indication of pituitary activity
(13). Twenty out of 22 analyses were within
normal limits (Table X). This finding indicates
that adrenal cortical function was normal be-
cause if it were decreased there would have been
a corresponding increase in the release of MSH.
The results are not what one would expect if the
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Case 5
Depigmented area on chest
Contralateral normal area
Depigmented area on knee
Adjacent normal skin
Depigmented area on thigh
Adjacent normal skin
Depigmented area on arm
Contralateral normal area
Case 6
Depigmented area on forehead
Contralateral normal area
Case 9
Depigmented area on right knee.
Adjacent normal skin
Depigmented area on left knee
Adjacent normal skin
Case 16
Center of perihalo nevus
Skin adjacent to pigmented area.
Depigmented area on knee
Depigmented area on knee
Adjacent normal skin
Adjacent normal skin
Depigmented area on face
Adjacent normal skin
Case 26
Depigmented area on chest
Adjacent normal skio
low 17-ketosteroid values meant hypoadrcnalism.
The two patients with increased excretion of
MSH had normal and not low 17-ketosteroid
levels in the urine.
Opposed to these findings are studies indicat-
ing that patients with alopecia areata excrete
increased amounts of MSH (14). In alopecia
areata hyperpituitarism may exist, whereas
pituitary function is normal in patients with
vitiligo who do not have alopecia areata. How-
ever, the local changes in vitiliginous skin in both
vitiligo and alopccia areata with vitiligo may he
similar.
TABLE VII
Thyroid Function
Patient
PBI Micrograms
per 100 ml.
serum
1131 24 Hour
Uptake BMR
1 5.2 — +9
2 4.9 26 —9
3 4.5 26 —14
4 4.2 32 —13
5 6.7 — —14
6 3.8 35 —1
7 5.1 — —
8 3.9 37 —12
9 3.6 20 —
10 4.1 25 +6
11 5.2 24 +13
12 4.7 18 —13
13 5.2 — —
14 4.2 26 +5
15 5.3 27 —
16 — — —12
17 6.6 43 —5
18 4.6 31 +3
19 6.5 27 —
20 6.0 49 +19
21 5.6 24 —11
22 5.0 14 —17
23 5.6 40 —
24 6.0 36 —
25 5.1 25 +21
Serum copper: Serum copper was determined
by the method of Nielson (15). This metal plays
a role in melanin formation because it is required
for tyrosinase activity. In addition, it is elevated
in the blood of patients with Addison's disease
and during pregnancy (16), two conditions with
hyperpigmentation.
Eleven of 12 analyses were normal (Table XI).
One value was low. Senim copper appears to be
of no significance in vitiligo although a tendency
to elevation has been reported (17).
Liver function: Two sensitive liver function
tests, thymol turbidity and cephalin cholesterol
flocculation, were carried out on most of the pa-
ticuts (Table XII). With but a single exception,
the tests were normal. On the basis of these tests,
patients with vitiligo have normal liver function.
TABLE VI
Electrical Conductivity of Skin Surface
Normal Range:
Protein Bound Iodine (PBI): 3—7 micrograms
per 100 ml. serum.
Reading I's' uptake 24 hours after injection of 50 micro-
curies of NaP31: 15—40 per cent. (10—50 per
cent is extreme range.)
53
25
30
7.5
70
40
60
5
75
0
50
2.5
25
5
100
5
70
75
45
50—60
75—90
2.5
100
5
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TABLE IX
17-Ketosteroid Excretion
Normal range:
Males: 10—20 mg. per 24 hours.
Females: 5—15 mg. per 24 hours.
VITILIGO
TABLE VIII
Basal Metabolic Rate (BMR) Data
The basal metabolic rate determinations were
done on post-prandial patients who had been at
rest in the morning for a period of at least 30
minutes. They were permitted to breathe room
air through a mouth piece, and the expired air
was collected in a Douglas bag. Basal analyses
were performed on the Scholander apparatus,
and all volumes and concentrations corrected on
the basis of ST. P.D. values. From the RQ, the
caloric equivalent was determined and the oxygen
consumption was calculated. This was compared
with standard tables and the BMR calculated
directly. The normal values of this laboratory
have usually been from —15 to 10.
Pa- Height Weight
tient (cm) (kg) RQ
Patient
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
Sex
M
M
M
M
M
F
F
F
F
F
F
F
F
F
F
F
F
F
F
F
F
F
F
F
F
l7-Ketosteroids Mg.
per 24 hour urine
5.2
12.5
5.2
8.6
8.5
8.2
8.9
4.4
9.1
16.4
5.2
5.3
13.0
6.5
8.1
8.5
8.5
4.2
3.2
4.6
Surface
Area
M2
1.44
1.85
1.98
2.03
1.86
1.69
1.61
1.56
1.86
1.52
2.08
1.86
1.68
1.48
1.40
1.56
1.77
1.52
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25*
Respi-
ratory
Minute
Vol.
liters/
mm.
4.62
5.63
4.84
6.46
5.51
5.32
4.32
5.41
5.83
4.07
7.21
5.61
4.38
4-54
4.88
3.07
4.44
5.61
165.1
170.2
181.2
182.8
187.8
163.6
163.6
167.4
176.3
163.6
170.0
166.0
167.4
148.6
157.2
159.8
167.4
164.2
43.2
74.0
77.5
82.0
65.0
63.0
56.5
52.0
70.5
49.8
98.0
77.0
60.0
55.0
44.5
54.5
68.0
47.5
Oxygen
Con-
sump-
tion
cc/mm.
233.8
232.5
220.2
232.6
198.4
231.5
181.0
211.0
246.0
264.4
2632
197.5
192.7
184.3
197.0
170.4
175.4
214.9
8MR
+9
—9
—14
—13
—14
—1
—12
+6
+13
—13
+5
—12
—5
+3
+19
—11
—17
+12
-79
.78
.99
.82
.77
.92
.80
.78
1.00
.76
.84
.83
.82
82
.91
.70
.82
.83
alopecia areata also are predisposed to the de-
velopment of vitiligo. Neoplasms, iritis and sym-
pathetic ophthalmia may be accompanied by an
increased incidence of vitiligo. The oniy consis-
tently abnormal finding in our study was in-
creased sweating in the hypopigmented areas
compared with the normal appearing skin.
Neurologic lesions in man provide ample
testimony to the relationship between vitiligo
and the nervous system. One patient, not in-
cluded in the metabolic study, had transverse
myelitis with paralysis from the waist down. She
developed vitiligo on the face and upper portion
of her body—neck, axillas, arms, hands. No
hypopigmentation occurred below the level of
cord damage. This was noteworthy since in a
patient with typical vitiligo, depigmentation
would have been expected over most of the body.
The patient underwent a hysterectomy, and no
depigmentation occurred in or near the surgical
scar. The patient's mother and a great aunt also
* This patient was very apprehensive during
the test procedure.
COMMENT
From our detailed metabolic studies of 25 pa-
tients, it is apparent that vitiligo occurs in
people whose general state of health is good. How-
ever, there is evidence that the incidence of
vitiligo is increased in hyperthyroidism, perni-
cious anemia and Addison's disease. Patients with
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TABLE X
Melanocyte Stimulating Hormone (MSH)
Excretion in Urine
Normal range: 8—48 units par 24 hours.
Patient MSH Units per 24 hnur urine
1 23
2 22
3 31
4 36
5 40
6 30
7 —
8 32
9 30
10 46
11 22
12 52
13 —
14 32
15 21
16 34
17 31
18 —
19 29
20 60
21 39
22 31
23 40
24 19
25 34
had vitiligo. Another patient developed vitiligo
several years after contracting poliomyelitis with
resulting nerve damage to one leg. Less depig-
mentation occurred over the leg with nerve
damage. In addition the observation that vitiligo
occurs more commonly in patients with perni-
cious anemia than in normal subjects (6) is con-
sistent with a neurologic defect's being com-
mon, at least in part, to both diseases.
Hypopigmented areas frequently are confined
to skin regions supplied by a nerve segment.
Failure to follow a pattern of segmental distribu-
tion could be explained by overlapping of the
peripheral fibers which originated from different
nerves. Panja described a patient with small
patches of hypopigmentation located at skin
sites corresponding to the apertures for sacral
nerves (4).
Our objective finding of increased sweating
in hypopigmented areas, together with reported
vasoconstriction (18), indicates the occurrence
Patient Copper Micrograms per 100 ml.serum
1 80
2 114
3 56
4 130
5 119
6 132
7 96
8 126
9 118
10 76
11 —
12 —
13 —
14 —
15 —
16 —
17 —
18 —
19 —
20 —
21 128
22 128
23 —
24 —
25 —
of some type of increased adrenergic nerve ending
activity in patches of vitiligo.
In animals such as frogs and fish neurogenic
control of the melanocytes can be demonstrated
dramatically (19—22). Cutting the sympathetic
fibers to a fish fin results in hyperpigmentation
of the fin distal to the ligation. This hyperpig-
mentation persists until the nerves regenerate.
Faradic stimulation of the nerves supplying a fin
results in marked lightening of the fin. Sub-
stances such as melatonin, noradrenaline, adrena-
line and serotonin are potent lightening agents
(22). These compounds are produced in neural
tissue. Recently melatonin was isolated from beef
pineal gland and shown to be present in periph-
eral nerves as well. This 5-hydroxyindole com-
pound is the most potent lightening agent known.
It can decrease the melanin content of normal
frog skin and of hamster melanomas (22).
When all these results are brought together it
Normal range:
serum.
TABLE XI
Serum Copper
75—165 micrograms per 100 ml.
TABLE XII
Liver Function Tests
Normal range:
Thymol turbidity: 0—5 units.
Cephalin cholesterol flocculation: Less than 3+
in 24 and 48 hours.
Patient Thymol Turbidity
C
24
ephalin C
hours
holesterol
48 hours
1 0 — —
2 5 — —
3 0 0 0
4 0 0 0
5 22 — —
6 0 0 0
7 0 0 0
8 0 0 0
9 0 0 0
10 0 0 0
11 0 — —
12 0 — —
13 0 0 0
14 0 0 0
15 0 0 0
16 0 0 0
17 0 — —
18 0 — —
19 0 0 0
20 0 2+ 2+
21 0 — —
22 0 — —
23 0 0 0
24 0 — —
25 — — —
is reasonable to conclude that vitiligo is the
result of increased activity of the peripheral
nerve endings in the skin. Melatonin or a related
substance elaborated by the nerve endings de-
creases the melanin forming capacity of the
melanocyte. Gray hair probably is caused by a
similar process.
5UMMARY
Data were obtained from 200 questionnaires
completed by patients with vitiligo. About 50
per cent of patients develop vitiligo before the
age of twenty. Hypopigmentation usually begins
on the exposed parts of the body. Approximately
50 per cent of patients have relatives with vitiligo.
This disease often is transmitted as a dominant
trait. The incidence of vitiligo in this country is
about one per cent.
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The clinical aspects of vitiligo are described.
It is shown that the usual areas of hypopigmen-
tation in vitiligo are the parts of the body that
are dark in normal subjects and greatly hyper-
pigmented in patients with Addison's disease.
A metabolic study performed on 25 patients
with vitiligo disclosed increased sweating in
vitiliginous areas with the patient at rest. No
change was observed in urinary noradrenaline
or MSH, serum copper, liver or thyroid function
tests or skin temperature. Urinary 17-ketosteroid
excretion may have been low, and hypochlor-
hydria but no achlorhydria may have been pres-
ent. While most patients with vitiligo have no
other disease there probably is an increased in-
cidence of vitiligo in patients with hyperthyroid-
ism, pernicious anemia and Addison's disease.
The hypothesis is suggested that vitiligo re-
sults from increased output at peripheral nerve
endings in the skin of an agent like melatonin
that lightens the color of pigment cells and de-
creases new melanin formation.
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